| 09:00 - 10:15 | Plenary Session 1: Opening Ceremony |
| 10:40 - 12:20 | Plenary Session 2: Immuno-oncology (1): Novel combinations, novel approaches |
| 13:45 - 15:15 | Plenary Session 3: Phase 1 Studies - Completed or in progress (miscellaneous drugs & targets) |
| 15:45 - 17:25 | Plenary Session 4: Early-phase drug development in hematology |
| 17:25 - 17:45 | Poster Awarding Ceremony |
| 17:45 - 19:00 | Poster Viewing & Reception |
| |
| 08:30 - 10:10 | Plenary Session 5: Immuno-oncology (2): Novel immune modulators |
| 10:40 - 12:20 | Plenary Session 6: Targeting the cell cycle |
| 12:30 - 13:30 | Meet-the-Professor Session: How to give a talk and how to write a paper: Tips to advance your career |
| 13:30 - 15:30 | Plenary Session 7: Targeted drug delivery: Next-generation antibody-drug conjugates and nanomedicines |
| 16:00 - 17:50 | Plenary Session 8: Clinical genomic profiling in early-phase clinical studies |
| |
| 08:30 - 10:10 | Plenary Session 9: Targeting cancer metabolism |
| 10:35 - 12:20 | Plenary Session 10: Miscellaneous drugs, targets and methods |
| 13:00 - 14:15 | Plenary Session 11: DNA-targeted therapies |
| 14:20 - 15:35 | Plenary Session 12: New targets in the androgen receptor pathway |
